Current price is more than the intrinsic value

Intrinsic Value

Returns vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Suven Pharma Consolidated September 2021 Net Sales At Rs 300.99 Crore, Up 26.79% Y-o-Y

Suven Pharma Standalone September 2021 Net Sales At Rs 300.99 Crore, Up 26.79% Y-o-Y

Suven Pharma - Healthy Q2, Strong Traction In Specialty Chemical: Dolat Capital

Suven Pharmaceuticals fell 2.66% to Rs 502 after the company announced its earnings for the quarter ended 30 September 2021.

Suven Pharma slips after Q2 earnings

Revenue from operations rose to Rs 301 crore for the quarter under review, as against Rs 237 crore in the year-ago period, Suven Pharmaceuticals said in a regulatory filing.

Q2 Results: Suven Pharma Posts 31% Increase In Net Profit, Divi’s Labs Net Profit Rises 17%

Suven Pharmaceuticals on Saturday posted a 31% increase in its consolidated net profit to ₹97 crore for the second quarter ended September 30. Revenue from operations rose to ₹301 crore for the quarte

Suven Pharma Q2 profit rises 31% to ₹97 cr.

Suven Pharma Q2 results: Net profit jumps 31% at Rs 97 crore

Suven Pharmaceuticals reported 76.3% rise in standalone net profit to Rs 115.19 crore in Q2 FY22 from Rs 65.33 crore in Q2 FY21.

Suven Pharma Q2 PAT up 76% YoY to Rs 115 crore

The Hyderabad-based company primarily operates in the contract development and manufacturing operations (CDMO) segment

Suven Pharma second quarter net profit up 31% at Rs 97 crore

Hyderabad-based Suven Pharma posts 31% jump to Rs 97 cr in net profit for September quarter

Suven Pharmaceuticals consolidated net profit rises 30.91% in the September 2021 quarter

Suven Pharmaceuticals is engaged in  Contract Research and Manufacturing Services (CRAMS), Drug Discovery & Development Support Services (DDDSS), Drug Discovery & Research/Clinical Pipeline, and Formulation Development

Suven Pharmaceuticals Ltd

Suven Pharmaceuticals Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Suven Pharma Consolidated September 2021 Net Sales At Rs 300.99 Crore, Up 26.79% Y-o-Y

Suven Pharma Standalone September 2021 Net Sales At Rs 300.99 Crore, Up 26.79% Y-o-Y

Suven Pharma - Healthy Q2, Strong Traction In Specialty Chemical: Dolat Capital

Suven Pharma slips after Q2 earnings

Q2 Results: Suven Pharma Posts 31% Increase In Net Profit, Divi’s Labs Net Profit Rises 17%

Suven Pharma Q2 profit rises 31% to ₹97 cr.

Suven Pharma Q2 results: Net profit jumps 31% at Rs 97 crore

Suven Pharmaceuticals Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Suven Pharma Consolidated September 2021 Net Sales At Rs 300.99 Crore, Up 26.79% Y-o-Y

Suven Pharma Standalone September 2021 Net Sales At Rs 300.99 Crore, Up 26.79% Y-o-Y

Suven Pharma - Healthy Q2, Strong Traction In Specialty Chemical: Dolat Capital

Suven Pharma slips after Q2 earnings

Q2 Results: Suven Pharma Posts 31% Increase In Net Profit, Divi’s Labs Net Profit Rises 17%

Suven Pharma Q2 profit rises 31% to ₹97 cr.

Suven Pharma Q2 results: Net profit jumps 31% at Rs 97 crore

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock